Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,873,199 papers from all fields of science
Search
Sign In
Create Free Account
rolofylline
Known as:
1,3-dipropyl-8-(3-noradamantyl)xanthine
, 1,3-dipropyl-8-(tricyclo(3.3.1.0(sup 3,7))non-3-yl)-3,7-dihydro-1h-purine-2,6-dione
, 1,3-DNAX
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (2)
Diuretics
Xanthines
Narrower (2)
KW-3902
MK 7418
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Placebo-Controlled Randomized Study of the Selective A 1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart
M. Givertz
,
D. Postmus
,
+11 authors
A. Voors
2018
Corpus ID: 198182679
METHODS AND RESULTS: In post hoc analyses, we analyzed the association of WRF with length of hospital stay, 30-day death or…
Expand
2018
2018
University of Groningen Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure
Licette C. Y. Liu
,
M. Valente
,
+15 authors
A. Voors
2018
Corpus ID: 54981595
Background Over the last 50 years, clinical trials of novel interventions for acute heart failure (AHF) have, with few exceptions…
Expand
2017
2017
Plasma biomarkers to determine individual response to rolofylline in acute heart failure: results from the PROTECT trial
Licette C. Y. Liu
,
M. Valente
,
+14 authors
A. Voors
2017
Corpus ID: 79795042
Background: Over the last 50 years, clinical trials of novel interventions for acute heart failure (AHF) have, with few…
Expand
2011
2011
Heart failure: Rolofylline fails to improve renal function in patients with acute HF
Gregory B. Lim
Nature Reviews Cardiology
2011
Corpus ID: 205470795
The adenosine A1 receptor antagonist rolofylline does not prevent persistent worsening of renal function in patients with acute…
Expand
2010
2010
Rolofylline for Acute Heart Failure? Maybe Not
H. Krumholz
,
Sm
2010
Corpus ID: 57071846
Declining renal function is common and a harbinger of poor outcome in patients with heart failure (HF). Research has suggested…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 31023199
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 29674848
O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC…
Expand
2009
2009
HOTLINE III: End of the line for rolofylline?
European Heart Journal
2009
Corpus ID: 45928619
2008
2008
Gateways to clinical trials. July-August 2008.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2008
Corpus ID: 23111308
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept…
Expand
1994
1994
Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
K. Nagashima
,
H. Kusaka
,
Kiyoshi Sato
,
Akira Karasawa
Japanese Journal of Pharmacology
1994
Corpus ID: 8406728
We investigated the possible renal protective effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a selective and…
Expand